Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 86
Selected: 0
NCT IDTitle
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT05448703A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis
NCT05583409SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
NCT02623595A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
NCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
NCT06810492The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
NCT03286348Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer
NCT06258863Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
NCT03801200Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
NCT02094638Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
NCT06032052Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients
NCT06401005SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
NCT02288195CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
NCT05219851The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
NCT03154983The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
NCT06713421Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT03595644Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer
NCT07263347DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
NCT06402435SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
NCT02974933Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
NCT06280313Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension
NCT05044871Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer
NCT06224842Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL
NCT07807722Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT02562599Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
NCT03230708Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites
NCT07264985Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
NCT05372198Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line
NCT05621473Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC
NCT07002346INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT05021328Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
NCT06020430Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
NCT07841210Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors
NCT04781686Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer
NCT06818955Orlistat Overcoming Third-generation EGFR-TKI Resistance
NCT05565014Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion
NCT06854107Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT06050109The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
NCT02605265Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
NCT06440018INSPIRE: a Multi-Cancer Early Detection Study
NCT05780372Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT07130643Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
NCT03663153SEMA4C as a Relapse Biomarker in Breast Cancer
NCT06037733Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
NCT07250204A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
NCT03716245Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer
NCT05004441Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
NCT04735861Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma